We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+12.53%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$3.25B
AUM Growth
+$307M
(+10%)
Cap. Flow
+$95.8M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
41.75%
Holding
101
New
19
Increased
28
Reduced
23
Closed
18
Top Buys
| 1 |
Cigna
CI
|
+$68.6M |
| 2 |
ALLK
Allakos
ALLK
|
+$59.9M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$58.6M |
| 4 |
Fate Therapeutics
FATE
|
+$43.8M |
| 5 |
Replimune Group
REPL
|
+$38.4M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$60.7M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$56.5M |
| 3 |
Labcorp
LH
|
+$51.8M |
| 4 |
Insmed
INSM
|
+$48.1M |
| 5 |
Centene
CNC
|
+$39.7M |
Sector Composition
| 1 | Healthcare | 93.71% |
| 2 | Financials | 1.28% |
| 3 | Energy | 0.69% |
| 4 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $242M | 7.44% |
15,906,680
-71,900
| -0.4% | -$1.1M |
|
2
Atara Biotherapeutics
ATRA
$76.8M
| $174M | 5.37% |
168,749
+3,684
| +2% | +$3.6M |
|
|
3
Fate Therapeutics
FATE
$336M
| $169M | 5.19% |
10,359,666
+3,703,704
| +56% | +$43.8M |
|
4
Regenxbio
RGNX
$622M
| $125M | 3.85% |
1,656,065
+94,890
| +6% | +$6.84M |
|
5
Xencor
XNCR
$1.1B
| $118M | 3.63% |
3,030,143
-116,900
| -4% | -$4.77M |
|
|
IMGN
6
DELISTED
Immunogen Inc
IMGN
| $117M | 3.59% |
12,309,035
-6,907
| -0.1% | -$66.4K |
|
7
Wave Life Sciences
WVE
$1.15B
| $114M | 3.5% |
2,273,307
+28,800
| +1% | +$1.3M |
|
|
ALDR
8
DELISTED
Alder Biopharmaceuticals
ALDR
| $108M | 3.33% |
6,505,766
| – | – |
|
|
FOLD
9
DELISTED
Amicus Therapeutics
FOLD
| $102M | 3.13% |
8,402,617
-2,109,115
| -20% | -$29.5M |
|
|
BOLD
10
DELISTED
Audentes Therapeutics, Inc
BOLD
| $88.8M | 2.73% |
2,243,356
+14,700
| +0.7% | +$548K |
|
|
11
Cigna
CI
$79.8B
| $77.1M | 2.37% |
+370,200
| New | +$68.6M |
|
12
LivaNova
LIVN
$4.41B
| $74.3M | 2.29% |
599,288
-500
| -0.1% | -$59K |
|
13
argenx
ARGX
$54.1B
| $73.9M | 2.27% |
974,506
+301,206
| +45% | +$26.7M |
|
14
InflaRx
IFRX
$299M
| $69.5M | 2.14% |
2,024,900
-2,800
| -0.1% | -$90.3K |
|
|
ALLK
15
DELISTED
Allakos
ALLK
| $65.7M | 2.02% |
+1,459,892
| New | +$59.9M |
|
16
Elevance Health
ELV
$84.7B
| $64.1M | 1.97% |
234,000
+88,000
| +60% | +$22.8M |
|
|
WMGI
17
DELISTED
Wright Medical Group Inc
WMGI
| $63.1M | 1.94% |
+2,173,700
| New | +$58.6M |
|
18
AnaptysBio
ANAB
$1.65B
| $62.9M | 1.93% |
630,250
+111,000
| +21% | +$9.21M |
|
19
uniQure
QURE
$2.78B
| $59.7M | 1.84% |
1,639,900
+15,500
| +1% | +$577K |
|
|
DCPH
20
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $57.2M | 1.76% |
1,476,580
-500
| -0% | -$18.5K |
|
|
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
| $52.2M | 1.61% |
1,778,300
+19,700
| +1% | +$763K |
|
22
ICU Medical
ICUI
$4B
| $51.5M | 1.58% |
181,972
-2,200
| -1% | -$644K |
|
|
WCG
23
DELISTED
Wellcare Health Plans, Inc.
WCG
| $50M | 1.54% |
155,909
-199,100
| -56% | -$56.5M |
|
24
Tandem Diabetes Care
TNDM
$1.07B
| $45.8M | 1.41% |
+1,069,670
| New | +$37.4M |
|
25
Scholar Rock
SRRK
$6.47B
| $45.7M | 1.4% |
1,773,107
+22,699
| +1% | +$417K |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO